Overview

Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of atomoxetine in treating children with attention deficit hyperactivity disorder symptoms associated with autistic disorder, Asperger's syndrome, and pervasive developmental disorder, not otherwise specified.
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Atomoxetine Hydrochloride